News Marker Therapeutics Announces Complete Response in First Lymphoma Patient Treated with MT-601 after CAR T Relapse Staff September 11, 2023 Iframe sync Post navigation Previous: APRINOIA Therapeutics Announces Strategic Investment From The Alzheimer’s Drug Discovery Foundation (ADDF)Next: Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer More Stories Healthcare News TelyRx Announces Departure of Chief Revenue Officer Staff November 18, 2026 Cancer Healthcare News Pharmaceutical Cosmos Health Reports Record Nine-Month Revenue of $53.6 Million, Up 18%; Q3 Gross Margin Up 465 Basis Points Sequentially; Total Debt Down 34% and Stockholders’ Equity Up 21% Since Year-End Staff November 18, 2026 Healthcare News Patient Care Pharmaceutical SpendMend Introduces Trulla IQ, the Next Generation of Pharmacy Procurement Technology Staff November 18, 2026